Cite Score:
0.73
ELSEVIER SCOPUS

Emergence of Cefepime Resistance in Gram-Negative Induced Nosocomial Infections

AUTHORS

Farzin Khorvash 1 , * , Kamyar Mostafavizadeh 1 , Sina Mobasherizadeh 1 , Mohaddeseh Behjati 1 , Mansoor Salehi 2

AUTHORS INFORMATION

1 Department of Infectious Diseases and Tropical Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran

2 Department of Molecular Genetics, Isfahan University of Medical Sciences, Isfahan, IR Iran

How to Cite: Khorvash F, Mostafavizadeh K, Mobasherizadeh S, Behjati M, Salehi M. Emergence of Cefepime Resistance in Gram-Negative Induced Nosocomial Infections, Arch Clin Infect Dis. Online ahead of Print ; 4(1):13-8.

ARTICLE INFORMATION

Archives of Clinical Infectious Diseases: 4 (1); 13-8
Article Type: Research Article

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: The rapid emergence of antibiotic resistance, especially broad-spectrum antibiotics, resulted in the avid use of new potent antibiotics. Ceftriaxone and ceftazidime, two third-generation cephalosporin, are usually used to manage complicated and uncomplicated infections. The use of cefepime in resistant infections is increasing gradually, which put this potent antibiotic at risk of resistance.

Patients and Methods: During an 18-month period, a total of 220 gram-negative bacteria including Pseudomonas spp, Serratia spp, Acinetobacter spp, Proteus spp, E-coli and Klebsiella spp. have been isolated by standard microbiological methods from nosocomial surgical site, abscess, blood stream and urinary tract infections. MIC of antibiotics on isolated bacteria was determined by gradient concentration method.

Results: Totally, 29.4%, 19.5% and 23.3% of isolated bacteria with MIC?8?g/ml were sensitive to cefepime, ceftriaxone and ceftazidime, respectively. High level resistance with MIC?256?g/ml to cefepime, ceftriaxone and ceftazidime was also observed in 47.1%, 70.8% and 62.5% of cases, respectively (p<0.05). High level resistance to cefepime were more commonly observed for pseudomonas (73.1%) and Klebsiella spp. (73.5%), respectively (p<0.05).

According to CLSI criteria, 47.1% of isolated bacteria in this study showed high level of resistance (MIC?256?g/ml) to cefepime. Therefore application of cefepime, as a drug of choice, for gram-negative organisms is not reasonable. Our result demonstrated that this potent antibiotic should not be used as a choice for empiric antibiotic therapy, in the cases of nosocomial infections caused by gram-negative organisms.

Keywords

Nosocomial infections, Gram-negative bacteria, MIC, Antibiotic resistance, Cephalosporins

© 0, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: